Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh
1
et al
1
European Centre for Disease Prevention and Control (ECDC)
1
Frase N. S.
1
Geneva Global Health Hub
1
Global Heart
1
Gojka Roglic, Cherian Varghese, Leanne Riley et al.
1
Greenpeace
1
IACAPAP
1
Imperial College COVID-19 Response Team
1
International Association for Child and Adolescent Psychiatry and Allied Professions
1
International Pharmaceutical Federation (FIP)
1
International Society of Nephrology
1
J. Wasserheit, H. Schünemann, et cl.
1
K. Hauck
1
Kengne, A.P. et al.
1
L. F. Owolabi
1
Latief, H.
1
Ministry of Health and Child Welfare, Zimbabwe
1
Ministry of Health, Republic of Kenya
1
N. M. Shehu
1
N.Puspito and F. Imamura
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Pan African Medical Journal
1
Pan American Health Organization
1
Quirk, E.J.
1
Rational Pharmaceutical Management Project
1
Rees, E.M.
1
S. D. Owolabi
1
Santesso, N.
1
Sliwa, K.
1
T. D. Vloet
1
T. Jans
1
The Lancet
1
The Republic of the Union of Myanmar, Ministry of Environmental Conservation and Forestry, National Environmental Conservation Committee
1
Thomas Jans Yesim Taneli Andreas Warnke
1
UN Children's Fund UNICEF
1
Vikram Patel, Melanie Abas, Jeremy Broadhead, et al.
1
WHO
1
World Health Organisation (WHO)
1
Y. Taneli
1
Yuen K. Y.
1
Yuyun, M.F.
1
Publication Years
2020-2024
17
2010-2019
16
2000-2009
3
Category
Non-communicable Diseases
6
Infection Control & Prevention (IPC)
2
Drugs & Medical Equipment
2
Studies & Reports
2
Surgery & Anaesthesia
2
HIV & STI
2
Cancer
1
COVID-19
1
Community Health
1
Other Cancer diseases
1
Countries
1
Pharmaceutical Assessments
1
Child protection
1
Policies
1
Guidelines
1
Women & Child Health
1
Community Health
1
WASH
1
Maternal Health
1
Neonatal Care
1
Disease Prevention & Control
1
Toolboxes
Children/Adolescents Mental Disorders
3
Africa
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Global Impact: Socio-economic, health services, TB & HIV
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these... or other herbal medicines; and
• facilitate information exchange among Member States.more
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a ...subset of indicators. Thirty-four of the indicators are quantitative, that is, expressed as numbers. Twelve are qualitative, in that they describe the presence or absence of a policy or management system, and in some cases, the degree of implementation.more
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...vision of the recommendation regarding the use of 80% fraction of inspired oxygen (high FiO2) in surgical patients under general anaesthesia with tracheal intubation and the update of the section on implementation. Between 2017 and 2018, WHO re-assessed the evidence on the use of high FiO2 by updating the systematic review related to the effectiveness of this intervention to reduce SSI and commissioning an independent systematic review on adverse events potentially associated with it. Based on the updated evidence, the GDG decided to revise the strength of the recommendation from strong to conditional.more
Aktualisiert: Debattenorientiertes Unterrichtsmaterial zu Klimaschutz, Klimapolitik und Klimagerechtigkeit zur Weltklimakonferenz 2018, Kohlekommission, Hambacher Wald und IPCC-Klima-Sonderbericht.
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...nfection. According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas. more
Sectors in which Priority Adaptation Projects should be implemented first include:
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir...d Priority Level Sector); and
- 4) Energy and Industry, and Biodiversity (Fourth Priority Level Sectors).
more
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available... through the public health system, compared to fewer than 15% of low-income countries, according to WHO.
But poorer countries can make substantial strides with a universal health coverage approach and use of the latest science to meet their particular needs.
The report lays out proven ways to prevent new cancer cases without breaking the bank, including tobacco-control measures and vaccines that protect against common cancers.more
The well-being of children in sub-Saharan Africa is under siege from all directions since the advent of the COVID-19 pandemic. The region is now suffering its first-ever economic recession, pushing about 50 million people into extreme poverty, a majority of whom are children.
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis....1 The impacts of medication errors also represent a
burden for health systems, with the annual cost associated with medication errors estimated at USD 42 billion
worldwideharmmore
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o...r mild respiratory signs. All unvaccinated ill horses in areas where flying foxes exist, may potentially be infected with HeV, posing a significant risk to the veterinary community. Equivac® HeV vaccine has been fully registered in Australia since 2015 (and under an Australian Pesticides and Veterinary Medicines Authority special permit since 2012) for immunization of horses against HeV and is the most effective and direct solution to prevent disease transmission to horses and protect humans. No HeV vaccinated horse has tested positive for HeV infection. There is no registered vaccine to prevent, or therapeutics to treat, HeV infection in humans. Previous equine HeV outbreaks tended to cluster in winter overlapping with the foaling season (August to December), when veterinarians and horse owners have frequent close contact with horses and their bodily fluids, increasing the chance of zoonotic disease transmission. The most southerly case was detected in 2019 in the Upper Hunter region in New South Wales, which is Australia's Thoroughbred horse breeding capital. Future spillover events are predicted to move further south and inland in Queensland and New South Wales, aligning with the moving distribution of the main reservoir hosts. Here we (1) review HeV epidemiology and climate change predicted infection dynamics, (2) present a biosecurity protocol for veterinary clinics and hospitals to adopt, and (3) describe diagnostic tests currently available and those under development. Major knowledge and research gaps have been identified, including evaluation of vaccine efficacy in foals to assess current vaccination protocol recommendations.more